AstraZeneca Pharma India results: Q2FY25 net profit falls 27% to Rs 38 cr
Revenue from operations stood at Rs 408 crore for the period under review compared with Rs 311 crore in the year-ago period
 "AstraZeneca")
Shares of the company ended 3.74 per cent lower at Rs 7,133.10 apiece on the BSE.
Listen to This Article
AstraZeneca Pharma India on Wednesday said its net profit declined by 27 per cent on-year to Rs 38 crore in the second quarter ended on September 30, 2024.
The drug firm reported a net profit of Rs 52 crore in the July-September quarter of last fiscal.
Revenue from operations stood at Rs 408 crore for the period under review compared with Rs 311 crore in the year-ago period, the firm said in a regulatory filing.
Shares of the company ended 3.74 per cent lower at Rs 7,133.10 apiece on the BSE.
More From This Section
 "Q2 earnings, Q2 result")
 "Q2 earnings, Q2")
 "Just a day ahead of the hurriedly called Vodafone Idea (Vi) meeting meant to soothe the nerves of investors amid the company's sliding stock price and a negative narrative around it, the telco announced a $3.6-billion (Rs 30,000 crore) deal with glob")
 "result, q1, q2, q3, q4")
 "Q2 earnings, Q2")
Topics : AstraZeneca Q2 results Pharma industry
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 13 2024 | 7:48 PM IST